Article ; Online: An audit of pharmaceutical continuous manufacturing regulatory submissions and outcomes in the US.
International journal of pharmaceutics
2022 Volume 622, Page(s) 121778
Abstract: Continuous manufacturing (CM) sends materials directly and continuously to the next step of a process, eliminating hold times and reducing processing times. The potential benefits of CM include improved product quality, reduced waste, lower costs, and ... ...
| Abstract | Continuous manufacturing (CM) sends materials directly and continuously to the next step of a process, eliminating hold times and reducing processing times. The potential benefits of CM include improved product quality, reduced waste, lower costs, and increased manufacturing flexibility and agility. Some pharmaceutical manufacturers have been hesitant to adopt CM owing to perceived regulatory risks such as increased time to regulatory approval and market entry, more difficulty submitting postapproval changes, and higher inspectional scrutiny. An FDA self-audit of regulatory submissions in the U.S. examined the outcomes, at approval and during the product lifecycle, of continuous manufacturing applications as compared to traditional batch applications. There were no substantial regulatory barriers identified for CM applications related to manufacturing process changes or pre-approval inspections. CM applicants had relatively shorter times to approval and market as compared to similar batch applications, based on the mean or median times to approval (8 or 3 months faster) and marketing (12 or 4 months faster) from submission, translating to an estimated $171-537 M in early revenue benefit. |
|---|---|
| MeSH term(s) | Pharmaceutical Preparations ; Technology, Pharmaceutical |
| Chemical Substances | Pharmaceutical Preparations |
| Language | English |
| Publishing date | 2022-04-29 |
| Publishing country | Netherlands |
| Document type | Journal Article |
| ZDB-ID | 428962-6 |
| ISSN | 1873-3476 ; 0378-5173 |
| ISSN (online) | 1873-3476 |
| ISSN | 0378-5173 |
| DOI | 10.1016/j.ijpharm.2022.121778 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 1409: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.